Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 January 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Trends in the subsite and morphology of esophageal and gastric cancer

Increase in adenocarcinoma of the gastric cardia is probably real, but interpretation is limited by the proportion of cancers without specified subsites or morphologies, find researchers in the latest issue of Alimentary Pharmacology and Therapeutics.

News image

fiogf49gjkf04

The incidence of adenocarcinoma of the esophagus and gastric cardia has increased in many countries.

Esophageal adenocarcinoma increased from 1.5 to 7.0 per 100,000 men between 1971 and 1998.
Alimentary Pharmacology and Therapeutics

In this study, researchers from England used cancer registry data, from 1971 to 1998, to describe the trends in the subsite and morphology of esophageal and gastric cancer.

The research team calculated the overall age-standardized incidence in each year. They also calculated the age-standardized incidence by subsite, by morphology, and by subsite and morphology. In addition, the team assessed the ratio of the rates in men and women in 1971 and 1998.

The team found that the incidence of esophageal adenocarcinoma increased from 1.5 to 7.0 per 100,000 men and from 0.4 to 1.5 per 100,000 women.

They also found that the incidence of cancer at the cardia also increased, from 2.0 to 5.4 per 100,000 men and from 0.6 to 1.4 per 100,000 women. However, the incidence of gastric cancer without a specified subsite decreased markedly from 21.3 to 9.3 per 100,000 men and from 10.7 to 4.2 per 100,000 women.

Dr Newnham's team concluded, "Although some of the increase in the incidence of adenocarcinoma of the gastric cardia is probably real, this interpretation is limited by the proportion of cancers without specified subsites or morphologies."

Aliment Pharmacol Ther 2003; 17(5): 665-76
17 March 2003

Go to top of page Email this page Email this page to a colleague

 24 January 2017 
H. pylori and iron deficiency anemia
 24 January 2017 
Hospital transfer and colorectal surgery
 24 January 2017 
Course of achalasia
 23 January 2017 
Fatigue in IBD after diagnosis
 23 January 2017 
Diagnosis of pancreatic cancer
 23 January 2017 
Care pathway for anemia in IBD 
 20 January 2017 
Abnormalities in functional dyspepsia
 20 January 2017 
Predictors of small bowel Crohn's in capsule endoscopy
 20 January 2017 
Stool output after a meal
 19 January 2017 
Prediction of chronic liver disease mortality
 19 January 2017 
Infliximab treatment algorithm in IBD
 19 January 2017 
Radiation exposure in IBD and IBS 
 18 January 2017 
Helicobacter pylori eradication and insulin resistance
 18 January 2017 
Hormone levels and NAFLD severity
 18 January 2017 
Measure of GERD
 17 January 2017 
Pediatric-onset Crohn's disease
 17 January 2017 
Biologic drugs and extraintestinal manifestations in IBD
 17 January 2017 
Colorectal cancer prevention among Medicare beneficiaries
 16 January 2017 
HCV eradication in cirrhosis
 16 January 2017 
Thyroid and primary biliary cholangitis
 16 January 2017 
Sarcopenia and severe liver fibrosis
 13 January 2017 
Early monocytopenia in paracetamol-induced liver failure
 13 January 2017 
Anti-TNF discontinuation in patients with IBD
 13 January 2017 
Isolated colonic Crohn's disease
 12 January 2017 
Providing relief for chronic constipation
 12 January 2017 
Internet-delivered therapy for adolescents with IBS
 12 January 2017 
NAFLD and coronary artery calcium score
 11 January 2017 
Fatigue in IBD
 11 January 2017 
Pancreatic cancer risk with asthma and nasal allergies
 11 January 2017 
PPIs and bone strength and structure
 10 January 2017 
Colorectal cancer risk in serrated polyposis syndrome
 10 January 2017 
Evaluation of abnormal liver chemistries
 10 January 2017 
Pelvic physiotherapy in functional constipation
 09 January 2017 
Intestinal microbiota and IBS
 09 January 2017 
Helicobacter and Campylobacter in IBD
 09 January 2017 
Diagnosis of microscopic colitis
 06 January 2017 
Recommendations on colorectal cancer screening 
 06 January 2017 
Colorectal cancer susceptibility gene variants
 06 January 2017 
Thiopurine-induced hepatotoxicity in IBD
 05 January 2017 
Histological index for ulcerative colitis
 05 January 2017 
Crohn's disease after total colectomy with permanent ileostomy
 05 January 2017 
Celiac disease screening in IBS
 04 January 2017 
Serrated colorectal polyps risk factors
 04 January 2017 
Score to predict eosinophilic esophagitis
 04 January 2017 
Platelet transfusion for gastrointestinal bleeding
 03 January 2017 
Pelvic physiotherapy for functional constipation in children
 03 January 2017 
Tumor necrosis factor antagonists in IBD
 03 January 2017 
Mesenchymal stromal cell therapy for IBD
 22 December 2016 
Happy holidays!
 21 December 2016 
Pharmacotherapy for NAFLD
 21 December 2016 
Predicting disease activity in eosinophilic esophagitis
 21 December 2016 
Breath Testing for Barrett’s esophagus
 20 December 2016 
H. pylori on the ethnic distribution of Barrett's metaplasia
 20 December 2016 
Prognostic biomarker in colorectal cancer
 20 December 2016 
Online health information for colorectal cancer screening
 19 December 2016 
Risk of tuberculosis in IBD
 19 December 2016 
Risk of complications of percutaneous liver biopsy
 19 December 2016 
Hospital research and colorectal cancer survival
 16 December 2016 
Predicting organ failure in acute pancreatitis
 16 December 2016 
Mortality rates for major causes of death

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us